Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Blood
|
May 15, 1995
In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells
F M Uckun, C F Stewart, G Reaman, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 1999
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines
W C Zamboni, P J Houghton, J L Hulstein, et al.
Journal of Neuro-Oncology
|
August 17, 1999
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study
R P Kadota, C F Stewart, M Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts
J Thompson, E O George, C A Poquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models
P J Houghton, C F Stewart, P J Cheshire, et al.
Investigational New Drugs
|
January 1, 1996
Topoisomerase I interactive drugs in children with cancer
C F Stewart, W C Zamboni, W R Crom, et al.
Journal of the National Cancer Institute
|
April 16, 1998
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts
W C Zamboni, C F Stewart, J Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma
W C Zamboni, A J Gajjar, T D Mandrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan
M K Ma, W C Zamboni, K M Radomski, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma
V M Daryani, Y T Patel, M Tagen, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Blood
|
May 15, 1995
In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells
F M Uckun, C F Stewart, G Reaman, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 1999
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines
W C Zamboni, P J Houghton, J L Hulstein, et al.
Journal of Neuro-Oncology
|
August 17, 1999
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study
R P Kadota, C F Stewart, M Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts
J Thompson, E O George, C A Poquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models
P J Houghton, C F Stewart, P J Cheshire, et al.
Investigational New Drugs
|
January 1, 1996
Topoisomerase I interactive drugs in children with cancer
C F Stewart, W C Zamboni, W R Crom, et al.
Journal of the National Cancer Institute
|
April 16, 1998
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts
W C Zamboni, C F Stewart, J Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma
W C Zamboni, A J Gajjar, T D Mandrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan
M K Ma, W C Zamboni, K M Radomski, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma
V M Daryani, Y T Patel, M Tagen, et al.
Page
of 10